Haemonetics Corporation Stock News

Synovus Financial Corp acquired a new stake in shares of Haemonetics Co. (NYSE:HAE) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 7,263 shares of the

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced it will present results

Haemonetics' (HAE) first-quarter fiscal 2021 results reflect impressive performance by Blood Center segment despite dismal overall performance during the coronavirus-led crisis.

It is hard to get excited after looking at Haemonetics' (NYSE:HAE) recent performance, when its stock has declined 26...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Haemonetics (HAE

Haemonetics (HAE) delivered earnings and revenue surprises of 12.20% and 1.35%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Shares of Haemonetics (NYSE:HAE) moved higher by 0.1% in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share were down 43.21% year over year to $0.46, which b

Haemonetics Corporation (NYSE:HAE) announced that financial results for its first quarter fiscal 2021, which ended June 27, 2020, are available on its Investor Relations website.

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) ABIOMED, Inc. (NASDAQ: ABMD) ALX Oncology Holdings Inc (NASDAQ: ALXO) Annexon Inc (NASDAQ: ANNX) Atossa...

Strs Ohio lifted its holdings in Haemonetics Co. (NYSE:HAE) by 37.9% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institution

Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flow continued to pour in,...

Haemonetics (HAE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced that it has entered int

Global investor focuses on positions in several ‘boring’ businesses Continue reading...

Haemonetics Co. (NYSE:HAE) has earned a consensus recommendation of “Buy” from the eight brokerages that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have ra